Jos Hermans

2.2k total citations
42 papers, 1.7k citations indexed

About

Jos Hermans is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Jos Hermans has authored 42 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 13 papers in Oncology and 11 papers in Pathology and Forensic Medicine. Recurrent topics in Jos Hermans's work include Lymphoma Diagnosis and Treatment (9 papers), Microfluidic and Capillary Electrophoresis Applications (5 papers) and Chronic Lymphocytic Leukemia Research (3 papers). Jos Hermans is often cited by papers focused on Lymphoma Diagnosis and Treatment (9 papers), Microfluidic and Capillary Electrophoresis Applications (5 papers) and Chronic Lymphocytic Leukemia Research (3 papers). Jos Hermans collaborates with scholars based in Netherlands, Italy and Austria. Jos Hermans's co-authors include M Krámer, J. Han van Krieken, P.M. Kluin, Katja Philippo, Ed Schuuring, Daphne de Jong, Eric Geelen, E. Maartense, Hanneke C. Kluin‐Nelemans and E.M. Noordijk and has published in prestigious journals such as Angewandte Chemie International Edition, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Jos Hermans

41 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jos Hermans Netherlands 20 816 653 399 299 284 42 1.7k
David M. Kurtz United States 22 717 0.9× 697 1.1× 881 2.2× 178 0.6× 500 1.8× 112 2.9k
George F. Tidmarsh United States 21 908 1.1× 604 0.9× 610 1.5× 275 0.9× 528 1.9× 46 2.8k
Samuel A. Jacobs United States 25 753 0.9× 1.4k 2.1× 620 1.6× 356 1.2× 450 1.6× 143 2.9k
Andreas Trojan Switzerland 22 214 0.3× 741 1.1× 339 0.8× 206 0.7× 295 1.0× 64 1.8k
John R. Murren United States 22 270 0.3× 998 1.5× 520 1.3× 207 0.7× 567 2.0× 65 1.9k
Donald C. Doll United States 18 255 0.3× 827 1.3× 247 0.6× 201 0.7× 303 1.1× 72 1.8k
Daniel Li United States 20 650 0.8× 996 1.5× 524 1.3× 867 2.9× 274 1.0× 63 2.3k
Antonio Gutiérrez Spain 28 978 1.2× 1.0k 1.5× 290 0.7× 271 0.9× 1.1k 3.9× 154 3.1k
Ye Guo China 28 412 0.5× 1.0k 1.6× 684 1.7× 100 0.3× 393 1.4× 217 2.3k
Louis A. Leone United States 26 368 0.5× 1.2k 1.8× 352 0.9× 158 0.5× 582 2.0× 59 2.4k

Countries citing papers authored by Jos Hermans

Since Specialization
Citations

This map shows the geographic impact of Jos Hermans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jos Hermans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jos Hermans more than expected).

Fields of papers citing papers by Jos Hermans

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jos Hermans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jos Hermans. The network helps show where Jos Hermans may publish in the future.

Co-authorship network of co-authors of Jos Hermans

This figure shows the co-authorship network connecting the top 25 collaborators of Jos Hermans. A scholar is included among the top collaborators of Jos Hermans based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jos Hermans. Jos Hermans is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hermans, Jos, et al.. (2025). Identification of Methylglyoxal Reactive Proteins with Photocaged Glycating Agents. ChemBioChem. 26(21). e202500275–e202500275.
2.
Kwiatkowski, Marcel, Justina C. Wolters, Albert Gerding, et al.. (2023). Effects of lysine deacetylase inhibitor treatment on LPS responses of alveolar-like macrophages. Journal of Leukocyte Biology. 115(3). 435–449. 2 indexed citations
3.
Hermans, Jos, et al.. (2023). Online coupling of a catalytic continuous microflow reactor to mass spectrometry. Talanta. 266(Pt 1). 124928–124928. 2 indexed citations
4.
Lingg, Nico, Arthur E. H. Bentlage, Natalia Govorukhina, et al.. (2021). Change of charge variant composition of trastuzumab upon stressing at physiological conditions. Journal of Chromatography A. 1655(6). 462506–462506. 15 indexed citations
5.
Hermans, Jos, et al.. (2020). Enhancement of amino acid production and secretion by Lactococcus lactis using a droplet-based biosensing and selection system. Metabolic Engineering Communications. 11. e00133–e00133. 24 indexed citations
7.
Galenkamp, Nicole Stéphanie, Misha Soskine, Jos Hermans, Carsten Wloka, & Giovanni Maglia. (2018). Direct electrical quantification of glucose and asparagine from bodily fluids using nanopores. Nature Communications. 9(1). 4085–4085. 108 indexed citations
8.
Bosch, Thea van den, Niek G.J. Leus, Hannah Wapenaar, et al.. (2017). A 6-alkylsalicylate histone acetyltransferase inhibitor inhibits histone acetylation and pro-inflammatory gene expression in murine precision-cut lung slices. Pulmonary Pharmacology & Therapeutics. 44. 88–95. 18 indexed citations
9.
Wapenaar, Hannah, Thea van den Bosch, Niek G.J. Leus, et al.. (2017). The relevance of K i calculation for bi-substrate enzymes illustrated by kinetic evaluation of a novel lysine (K) acetyltransferase 8 inhibitor. European Journal of Medicinal Chemistry. 136. 480–486. 5 indexed citations
10.
Hermans, Jos, Natalia Govorukhina, Nick H.T. ten Hacken, et al.. (2016). Quantitative antibody-free LC–MS/MS analysis of sTRAIL in sputum and saliva at the sub-ng/mL level. Journal of Chromatography B. 1032. 205–210. 8 indexed citations
11.
Boichenko, Alexander P., Thea van den Bosch, Jos Hermans, et al.. (2016). Site-specific quantification of lysine acetylation in the N-terminal tail of histone H4 using a double-labelling, targeted UHPLC MS/MS approach. Analytical and Bioanalytical Chemistry. 408(13). 3547–3553. 7 indexed citations
12.
Ongay, Sara, Péter Horvatovich, Jos Hermans, et al.. (2016). Free Urinary Desmosine and Isodesmosine as COPD Biomarkers: The Relevance of Confounding Factors. Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation. 3(2). 560–569. 10 indexed citations
14.
Nagtegaal, Irıs D., Elma Meershoek‐Klein Kranenbarg, Jos Hermans, C.J.H. van de Velde, & J. Han van Krieken. (2000). Pathology Data in the Central Databases of Multicenter Randomized Trials Need to Be Based on Pathology Reports and Controlled by Trained Quality Managers. Journal of Clinical Oncology. 18(8). 1771–1779. 51 indexed citations
15.
Bleeker, Wim, et al.. (2000). Impact of Kras and Tp53 Mutations on Survival in Patients With Left- and Right-Sided Dukes' C Colon Cancer. The American Journal of Gastroenterology. 95(10). 2953–2957. 61 indexed citations
16.
Schuuring, Ed, FJ Bot, Jos Hermans, et al.. (1999). Gastric low-grade MALT lymphoma, high-grade MALT lymphoma and diffuse large B cell lymphoma show different frequencies of trisomy. Leukemia. 13(5). 799–807. 50 indexed citations
17.
Krieken, JHJM van, et al.. (1998). Immunohistochemical detection of p53 and Bcl-2 in colorectal carcinoma: no evidence for prognostic significance. British Journal of Cancer. 77(11). 1842–1847. 60 indexed citations
18.
Krámer, M, Jos Hermans, Jefferson Parker, et al.. (1996). Clinical significance of bcl2 and p53 protein expression in diffuse large B-cell lymphoma. Journal of Clinical Oncology. 14(7). 1 indexed citations
19.
Velders, Gerjo A., Hanneke C. Kluin‐Nelemans, Carla J. de Boer, et al.. (1996). Mantle-cell lymphoma. Journal of Clinical Oncology. 14(4). 3 indexed citations
20.
Velders, Gerjo A., Hanneke C. Kluin‐Nelemans, Carla J. de Boer, et al.. (1996). Mantle-cell lymphoma: a population-based clinical study.. Journal of Clinical Oncology. 14(4). 1269–1274. 143 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026